Table 1.
Impact of selected components of cigarette smoke and next-generation tobacco/nicotine products on endothelial function (modified after [28, 74])
| Substance | Unit | HnB-tobacco sticks [64] | Conventional cigarettes [16] | Reduction (%) | Impact on endothelial function |
|---|---|---|---|---|---|
| Nicotine | mg/tobacco sample* | 1.1 | 1.07–2.70 | - | Promotes endothelial dysfunction and release of catecholamines [20] and causes hemodynamic changes (e.g. alteration of heart rate and blood pressure, vasoconstriction) [5, 8, 36] |
| Acetaldehyde | μg/tobacco sample | 179.4–183.5 | 930–1540 | 80.7–88.5 | Inhalation of acetaldehyde gases at smoke-relevant concentrations impairs flow-mediated dilation (FMD) by 50 % [71] |
| Acrolein | μg/tobacco sample | 8.9–9.9 | 89.2–154.1 | 90.0–94.2 | Promotes endothelial dysfunction, oxidative stress, dyslipidemia, and platelet activation [13, 20, 55, 89, 93, 100] |
| Formaldehyde | μg/tobacco sample | 4.7–5.3 | 29.3–130.3 | 84.0–96.4 | Induces endothelial dysfunction [47] |
| Crotonaldehyde | μg/tobacco sample | <3.0 | 32.7–70.8 | 90.8–95.8 | Induces vascular injury via DNA interstrand crosslinks, glutathione perturbation, mitogen–activated protein kinase, and Wnt and ErbB signaling pathways [105] and at higher concentrations tension oscillations (spasms) and irreversibly impaired contractility [46] |
| Benzene | μg/tobacco sample | 0.5–0.6 | 49.7–98.3 | 99.0–99.5 | Increases low-density lipoprotein, decreases circulating angiogenic cells, and increases cardiovascular risk scores [1] |
| 1,3 Butadiene | μg/tobacco sample | 0.2 | 77.0–116.7 | 99.7–99.8 | Promotes oxidative stress and atherosclerosis [78] |
*Tobacco samples are defined as one tobacco stick of HnB tobacco products and one conventional cigarette. The studies used the Health Canada Intense (HCI) protocol